Phenotypic variation resulting from a deficiency of epidermal growth factor receptor in mice is caused by extensive genetic heterogeneity that can be genetically and molecularly partitioned

Genetics

Volumn 167, Issue 4, 2004, Pages 1821-1832

  Strunk, Karen E ^a,b   Amann, Vicky ^a   Threadgill, David W ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MUTANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREEDING; CONGENIC STRAIN; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE MAPPING; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HOMOZYGOSITY; LETHALITY; MALE; MOLECULAR GENETICS; MOUSE; MOUSE STRAIN; NONHUMAN; NULL ALLELE; NUTRIENT SUPPLY; PARTITION COEFFICIENT; PHENOTYPE; PLACENTA; PREGNANCY; PRIORITY JOURNAL; YOLK SAC;

ANIMALS; BASE SEQUENCE; CROSSES, GENETIC; DNA PRIMERS; EMBRYONIC DEVELOPMENT; FEMALE; GENOTYPE; GESTATIONAL AGE; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, MUTANT STRAINS; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; RECEPTOR, EPIDERMAL GROWTH FACTOR; VARIATION (GENETICS);

ANIMALIA; MAMMALIA;

EID: 2942715388     PISSN: 00166731     EISSN: None     Source Type: Journal    
DOI: 10.1534/genetics.103.020495     Document Type: Article

References (40)

1. ALROY, I., and Y. YARDEN, 1997 The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett. 410: 83-86.
2. ARTEAGA, C. L., and J. BASELGA, 2003 Clinical trial design and end points for epidermal growth factor receptor-targeted therapies: implications for drug development and practice. Clin. Cancer Res. 9: 1579-1589.
3. BECK, J. A., S. LLOYD, M. HAFEZPARAST, M. LENNON-PIERCE, J. T. EPPIG et al., 2000 Genealogies of mouse inbred strains. Nat. Genet. 24: 23-25.
4. CARPENTER, G., and M. I. WAHL, 1990 The epidermal growth factor family, pp. 69-171 in Handbook of Experimental Pharmacology, Peptide Growth Factors and Their Receptors I, edited by M. B. SPORN and A. B. ROBERTS. Springer-Verlag, Berlin.
5. CASLEY, W. L., J. A. MENZIES, N. MOUSSEAU, M. GIRARD, T. W. MOON et al., 1997 Increased basal expression of hepatic Cyp1a1 and Cyp1a2 genes in inbred mice selected for susceptibility to acetaminophen-induced hepatotoxicity. Pharmacogenetics 7: 283-293.
6. CIARDIELLO, F., N. KIM, T. SAEKI, R. DONO, M. G. PERSICO et al., 1991 Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc. Natl. Acad. Sci. USA 88: 7792-7796.
7. COHEN, S., 1962 Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J. Biol. Chem. 237: 1555-1562.
8. CRISPENS, C. G., 1973 Some characteristics of strain SJL-JDg mice. Lab. Anim. Sci. 23: 408-413.
9. DASSONVILLE, O., J. L. FORMENTO, M. FRANCOUAL, A. RAMAIOLI, J. SANTINI et al., 1993 Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J. Clin. Oncol. 11: 1873-1878.
10. DERISI, J., L. PENLAND, P. O. BROWN, M. L. BITTNER, P. S. MELTZER et al., 1996 Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 14: 457-460.
11. ELENIUS, K., S. PAUL, G. ALLISON, J. SUN and M. KLAGSBRUN, 1991 Activation of HER4 by heparin-binding -like growth factor stimulates chemotaxis but not proliferation. EMBO J. 16: 1268-1278.
12. EVANS, J., T. HAUSCHKA and A. MITTELMAN, 1974 Differential susceptibility of four mouse strains to induction of multiple large bowel neoplasms by 1,2-dimethylhydrazine. J. Natl. Cancer Inst. 52: 999-1000.
13. FONDACCI, C., E. ALSAT, R. GABRIEL, P. BLOT, C. NESSMANN et al., 1994 Alterations of human placental epidermal growth factor receptor in intrauterine growth retardation. J. Clin. Invest. 93: 1149-1155.
14. FOWLER, K. J., F. WALKER, W. ALEXANDER, M. L. HIBBS, E. C. NICE et al., 1995 A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on the receptor biochemistry that results in impaired lactation. Proc. Natl. Acad. Sci. USA 92: 1465-1469.
15. GRANDIS, J. R., M. F. MELHEM, W. E. GOODING, R. DAY, V. A. HOLST et al., 1998 Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J. Natl. Cancer Inst. 90: 824-832.
16. GRASER, R. T., C. E. MATHEWS, E. H. LEITER and D. V. SERREZE, 1999 MHC characterization of ALR and ALS mice: respective similarities to the NOD and NON strains. Immunogenetics 49: 722-726.
17. GRUNWALD, V., and M. HIDALGO, 2003 Developing inhibitors of the epidermal growth factor receptor for cancer treatment. J. Natl. Cancer Inst. 95: 851-867.
18. GULLICK, W. J., 1998 Type I growth factor receptors: current status and future work. Biochem. Soc. Symp. 63: 193-198.
19. HESTON, W. E., 1963 Genetics of neoplasia, pp. 247-268 in Methodology in Mammalian Genetics, edited by W. J. BURDETTE. Holden-Day, San Francisco.
20. HIGASHIYAMA, S., J. A. ABRAHAM, J. MILLER, J. C. FIDDES and M. KLAGSBRUN, 1991 A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251: 936-939.
21. JANSEN, R. C., and J. P. NAP, 2001 Genetical genomics: the added value from segregation. Trends Genet. 17: 388-391.
22. LEITER, E. H., P. C. REIFSNYDER, K. FLURKEY, H. J. PARTKE, E. JUNGER et al., 1998 NIDDM genes in mice: deleterious synergism by both parental genomes contributes to diabetogenic thresholds. Diabetes 47: 1287-1295.
23. LUETTEKE, N. C., H. K. PHILLIPS, T. H. QIU, N. G. COPELAND, H. S. EARP et al., 1994 The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev. 8: 399-413.
24. MARQUARDT, H., M. M. HUNKAPILLER, L. E. HOOD and G. J. TODARO, 1984 Rat transforming growth factor type I: structure and relation to epidermal growth factor. Science 223: 1079-1082.
25. MENDELSOHN, J., and J. BASELGA, 2003 Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J. Clin. Oncol. 21: 2787-2799.
26. MIETTINEN, P. J., J. E. BERGER, J. MENESES, Y. PHUNG, R. A. PEDERSEN et al., 1995 Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376: 337-341.
27. PEROU, C. M., S. S. JEFFREY, M. VAN DE RIJN, C. A. REES, M. B. EISEN et al., 1999 Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl. Acad. Sci. USA 96: 9212-9217.
28. RICKMAN, D. S., M. P. BOBEK, D. E. MISEK, R. KUICK, M. BLAIVAS et al., 2001 Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res. 61: 6885-6891.
29. RIESE, D. J., Y. BERMINGHAM, T. M. VAN RAAIJ, S. BUCKLEY, G. D. PLOWMAN et al., 1996 Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor receptor or neuregulin-β. Oncogene 12: 345-353.
30. RIESE, D. J., T. KOMURASAKI, G. D. PLOWMAN and D. F. STERN, 1998 Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2. J. Biol. Chem. 273: 11288-11294.
31. RUSCH, V., J. BASELGA, C. CORDON-CARDO, J. ORAZEM, M. ZAMAN et al., 1993 Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res. 53: 2379-2385.
32. SHING, Y., G. CHRISTOFORI, D. HANAHAN, Y. ONO, R. SASADA et al., 1993 Betacellulin: a novel mitogen from pancreatic β-tumor cells. Science 259: 1604-1607.
33. SIBILIA, M., and E. F. WAGNER, 1995 Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269: 234-238.
34. STRACHAN, L., J. G. MURISON, R. L. PRESTIDGE, M. A. SLEEMAN, J. D. WATSON et al., 2001 Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily. J. Biol. Chem. 276: 18265-18271.
35. TEWARI, K. S., A. S. KYSHTOOBAYEVA, R. S. MEHTA, I. R. YU, R. A. BURGER et al., 2000 Biomarker conservation in primary and metastatic epithelial ovarian cancer. Gynecol. Oncol. 78: 130-136.
36. THREADGILL, D. W., A. A. DLUGOSZ, L. A. HANSEN, T. TENNENBAUM, U. LICHTI et al., 1995 Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269: 230-234.
37. TOYODA, H., T. KOMURASAKI, D. UCHIDA, Y. TAKAYAMA, T. ISOBE et al., 1995 Epiregulin: a novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J. Biol. Chem. 270: 7495-7500.
38. UMEKITA, Y., Y. OHI, Y. SAGARA and H. YOSHIDA, 2000 Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients. Int. J. Cancer 89: 484-487.
39. WAYNE, M. L., and L. M. MCINTYRE, 2002 Combining mapping and arraying: an approach to candidate gene identification. Proc. Natl. Acad. Sci. USA 99: 14903-14906.
40. YANG, Y. H., S. DUDOIT, P. LUU, D. M. LIN, V. PENG et al., 2002 Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30: e15.